CBAN

Colony Bankcorp, Inc. Financial Services - Banks - Regional Investor Relations →

NO
51.1% ABOVE
↓ Approaching Was 55.7% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $13.61
14-Week RSI 60
Rel. Volume (14w) This week's trading vs. the 14-week average 0.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.15

Colony Bankcorp, Inc. (CBAN) closed at $20.56 as of 2026-06-19, trading 51.1% above its 200-week moving average of $13.61. The stock is currently moving closer to the line, down from 55.7% last week. The 14-week RSI sits at 60, indicating neutral momentum.

Trading volume is running at 0.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.15 ratio) is neutral — neither side is clearly dominating.

Over the past 1424 weeks of data, CBAN has crossed below its 200-week moving average 16 times. On average, these episodes lasted 36 weeks. Historically, investors who bought CBAN at the start of these episodes saw an average one-year return of +8.3%.

With a market cap of $435 million, CBAN is a small-cap stock. Return on equity stands at 8.9%. The stock trades at 1.1x book value.

Share count has increased 20.8% over three years, indicating dilution.

Over the past 27.3 years, a hypothetical investment of $100 in CBAN would have grown to $373, compared to $938 for the S&P 500. CBAN has returned 4.9% annualized vs 8.5% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CBAN vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CBAN Crosses Below the Line?

Across 16 historical episodes, buying CBAN when it crossed below its 200-week moving average produced an average return of +9.5% after 12 months (median +20.0%), compared to +8.8% for the S&P 500 over the same periods. 62% of those episodes were profitable after one year. After 24 months, the average return was +23.6% vs +8.2% for the index.

Each line shows $100 invested at the moment CBAN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CBAN would reach each dislocation threshold.

Current Bean Score -1.17σ
Current FCF Yield 6.85%
Baseline Yield 6.94%
Historical σ 0.16pp

Dislocation Price Levels

Prices where CBAN's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).

LevelσPriceSignal
Deep Value+2σ$18.84Unusually cheap — potential buy zone
Value+1σ$19.26Cheap vs. own history
Fair Value+0σ$19.70Historical mean behavior
Expensive-1σ$20.16Expensive vs. own history
Deep Expensive-2σ$20.64Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CBAN's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation -0.35σ Dividend yield vs own 10-yr norm
Drawdown Score -0.96σ Distance from line vs own history
Sector-Relative -0.92σ Vs sector median this week
Buyback Acceleration +14.8pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 77th TTM buys / market cap, percentile of buyers
FCF Yield vs History N/A Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+32.8pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

CBAN has crossed below its 200-week MA 16 times with an average 1-year return of +8.3% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 1999Apr 199910.5%-14.0%+279.4%
May 1999Dec 19993312.0%-14.0%+279.4%
Jan 2000Jan 20014924.2%+5.9%+298.6%
Feb 2001Apr 2001612.6%+19.9%+325.5%
May 2001Jun 200147.8%+31.5%+341.5%
Jun 2001Jul 2001311.6%+34.4%+361.2%
Aug 2001Oct 20011015.7%+40.9%+315.2%
May 2006Jun 200676.6%+23.7%+67.7%
Oct 2006Mar 20072211.1%+0.3%+52.1%
Jun 2007Jun 201226172.3%-42.2%+37.7%
Jun 2012Jan 20133030.5%+46.0%+411.9%
Mar 2020Nov 20203930.3%+17.8%+90.1%
Jan 2021Feb 202112.2%+25.9%+76.0%
Jun 2022Jun 202211.2%-32.5%+59.2%
Jul 2022Dec 20237537.6%-31.1%+58.1%
Jan 2024Jul 20242618.4%+20.0%+75.2%
Average36+8.3%

Frequently Asked Questions

Is CBAN below its 200-week moving average?

No. Colony Bankcorp, Inc. (CBAN) is currently 51.1% above its 200-week moving average of $13.61. It would need to fall to $13.61 to cross below the line.

What is CBAN's 200-week moving average price?

Colony Bankcorp, Inc.'s 200-week moving average is $13.61 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CBAN drops below its 200-week moving average?

CBAN has crossed below its 200-week moving average 16 times in our data. On average, buying at that moment produced a one-year return of +8.3%. These dips have historically been decent entry points. These episodes lasted 36 weeks on average.

Is CBAN a good value right now?

Here's what our data says about CBAN as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 60. Return on equity is 8.9%. Price-to-book is 1.1x. This is not a buy or sell recommendation — always do your own research.

How does CBAN compare to the S&P 500?

Over the past 27.3 years, $100 invested in CBAN would have grown to $373, compared to $938 for the S&P 500. That's 4.9% annualized vs 8.5% for the index. CBAN has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19